This website uses cookies to enhance the user experience.
||
N

NOVO NORDISK NORWAY AS918 229 353

Purchase and sale
Limited company
Nydalsveien 28 0484 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

NOVO NORDISK NORWAY AS

Operating
Omsetning av legemidler fremstilt av Novo Nordisk AS, København.
Å drive opplysningsvirksomhet og reklame for Norge registrerte legemidler, fremstillet av Novo Industri AS, København.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
NT

Nina Therese Hovland1971

Chairman of the board
JE

Jonas Emil Kongshøj Larsen1975

Years since formation
30 years
since Feb 19, 1995
Type
Limited company
VAT registered
Yes
Number of employees
90

Ownership

Number of shares and share classes
250
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
2,992,555,971
NOK
Annual total result 2024
117,236,419
NOK
Total equity 2024
3,899,762
NOK
Last update: Dec 13, 2025

Management

Management / administration

NameRoleShares
NT

Nina Therese Hovland

1971

Managing Director/CEO-

Board

NameRoleShares
JE

Jonas Emil Kongshøj Larsen

1975

Chairman-
MV

Mads Veggerby Lausten

1974

Board Member-
ME

Malin Eva Maria Arvling Andreasen

1971

Board Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
G
GRANT THORNTON ØKONOMISERVICE AS
Accountant-
S
SPAREBANK 1 FORRETNINGSPARTNER ØSTLANDET AS
Accountant-
Last update: Nov 6, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
NR

Nordisk Region Europe As Novo

Ordinary shares
250
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
2,992,555,971
2,453,865,300
1,571,544,321
1,045,655,739
Annual Total Result
117,236,419
78,089,795
45,028,639
17,452,511
Total assets
846,193,235
1,545,702,793
699,007,362
594,619,959
Total liabilities
842,293,473
1,542,039,449
696,433,811
592,075,047
Total equity
3,899,762
3,663,345
2,573,550
2,544,911

P&L

Year2024202320222021
Total operating income
2,992,555,971
2,453,865,300
1,571,544,321
1,045,655,739
Total operating costs
2,888,015,619
2,369,538,211
1,517,447,340
1,023,088,685
Operating result
104,540,352
84,327,089
54,096,981
22,567,054
Financial income/costs
46,535,787
17,803,097
4,886,585
406,687
Profit before tax
151,076,139
102,130,186
58,983,566
22,973,741
Total tax & extraordinary income/cost
33,839,720
24,040,391
13,954,927
5,521,230
Annual Total Result
117,236,419
78,089,795
45,028,639
17,452,511

Balance overview

Year2024202320222021
Total fixed assets
1,639,902
2,695,827
2,869,205
2,616,278
Total current assets
844,553,333
1,543,006,966
696,138,157
592,003,681
Total assets
846,193,235
1,545,702,793
699,007,362
594,619,959
Short term debt
841,711,297
1,540,517,611
692,887,394
589,900,040
Long term debt
582,176
1,521,838
3,546,417
2,175,007
Total liabilities
842,293,473
1,542,039,449
696,433,811
592,075,047
Contributed capital
250,000
250,000
250,000
250,000
Retained earnings
3,649,762
3,413,345
2,323,550
2,294,911
Total equity
3,899,762
3,663,345
2,573,550
2,544,911
Total equity and liabilities
846,193,235
1,545,702,794
699,007,361
594,619,958

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods